Activity

Filter

Cancel
Date Panel Item Activity
5 actions
Disorders of immune dysregulation v2.4 PPL chirag patel Marked gene: PPL as ready
Disorders of immune dysregulation v2.4 PPL chirag patel Gene: ppl has been classified as Green List (High Evidence).
Disorders of immune dysregulation v2.4 chirag patel Copied gene PPL from panel Mendeliome
Disorders of immune dysregulation v2.4 PPL chirag patel gene: PPL was added
gene: PPL was added to Disorders of immune dysregulation. Sources: Expert Review Green,Literature
Mode of inheritance for gene: PPL was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: PPL were set to 34815391
Phenotypes for gene: PPL were set to Eosinophilic esophagitis, MONDO:0005361
Disorders of immune dysregulation v1.27 GNAI2 Zornitza Stark gene: GNAI2 was added
gene: GNAI2 was added to Disorders of immune dysregulation. Sources: Literature
Mode of inheritance for gene: GNAI2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: GNAI2 were set to 31036916; 40926810; 39298586
Phenotypes for gene: GNAI2 were set to Syndromic disease MONDO:0002254, GNAI2-related
Review for gene: GNAI2 was set to GREEN
Added comment: PMID: 40926810 | 20 individuals from 18 families with a multisystem syndrome termed MAGIS (“Midline malformations of the brain, Anterior pituitary gland dysfunction, Growth retardation, Immunodysregulation/immunodeficiency, and Skeletal defects”) caused by heterozygous germline activating mutations. Considerable phenotypic heterogeneity with inter- and intra-familial variability. Majority of variants occur at recurrent residues Thr182 (Thr182Ala/Ile/Pro in six families) and Arg179 (Arg179His/Cys in seven patients from five families). The patients’ mutations were clustered in the P-loop and switch regions of the Ras-like domain of Gα, which is critical for guanine-nucleotide binding and GTPase activity. See PMID: 39298586 supplementary data for patient details of the above cohort. Other common features in the cohort also include intellectual disability (9/17), neurodevelopmental delay (13/19), motor delay (13/19), deafness (11/15), cryptochordism (7/14).

Immune-mediated disease (95%) is widely present in MAGIS as both immunodeficiency (90%) and immune dysregulation (50%; systemic autoinflammation, 15%, autoimmunity, 35%, and splenomegaly, 35%).
Sources: Literature